AUSCAN Osteoarthritis Index

Home | WOMAC® 3.1
| AUSCAN 3.1
| OGI 8.0 | Contact |

AUSCAN 3.1 User Guide

The following is the Table of Contents from the AUSCAN 3.1 User Guide IV.



Conceptual Basis

Derivation of the Item Inventory

Validation Studies (Reliability, Validity, Responsiveness)

Validity and Reliability Study
Responsiveness Study

Specific Clinimetric Issues

Likert vs Visual Analogue vs Numerical Rating Scale Formats
Weighting and Aggregation
Alternate Language Translations
Relative Responsiveness
Applications in non-OA disorders

Post-Validation Studies

Quality Ratings
Clinimetric Analyses
Clinical Trials
Structure and Symptoms

Administrative Issues

Formatting the Index
Index Presentation
Score Calculation
Statistical Issues

Score Interpretation Issues

Responder Criteria
State-attainment Criteria
Population-based Age- and Gender-Specific Normative Values

Guidance Document

OMERACT Core Set Measures for OA
OARSI Clinical Trials Guidelines
IMMPACT Guidelines for Pain Studies
FDA Guidance Document on Patient Reported Outcome Measures



Appendix I: Alternate Language Translations
Appendix II: An Explanation Of The Meaning of Questions In The AUSCANTM Hand Osteoarthritis Index Inventory

Related Osteoarthritis PRO Measures

Western Ontario and McMaster (WOMAC®) Osteoarthritis Index
Osteoarthritis Global Index (OGI)
Osteoarthritis Modular Measurement System (O2MS)

Return to AUSCAN 3.1 Index

WOMAC® is a registered trade-mark
(CDN No. TMA 545,986), (EU No. 004885235), (USA No. 3520667)

Page last updated; July 2016

| Home | Back to top